Market Research Logo

Alchemia Ltd (ACL) - Financial and Strategic SWOT Analysis Review

Alchemia Ltd (ACL) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Alchemia Ltd (Alchemia) is a biopharmaceutical company that focuses on the discovery and development of drugs for the treatment of cancer and respiratory disorders. It sold the worldwide exclusive intellectual property rights to its product, Fondaparinux sodium (a generic version of the anticoagulant drug Arixtra, approved in the US and Europe for the treatment of deep vein thrombosis and pulmonary embolism), to Dr. Reddy’s Laboratories. The company is developing a late stage cancer product pipeline derived from the HyACT platform, and has a proprietary drug discovery platform, VAST, derived from its chemistry expertise. Alchemia is headquartered in South Melbourne, Victoria, Australia.

Alchemia Ltd Key Recent Developments

Jun 29,2016: Alchemia Announces Resignation of Non-Executive Director
Apr 11,2016: Alchemia Announces Change Of Company Secretary
Mar 07,2016: Alchemia Announces Appointment of Non - Executive Director
Feb 29,2016: Alchemia Announces Appointment of Non - Executive Chairman and Retirement of Non - Executive Chairman

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Alchemia Ltd - Key Facts
Alchemia Ltd - Key Employees
Alchemia Ltd - Key Employee Biographies
Alchemia Ltd - Major Products and Services
Alchemia Ltd - History
Alchemia Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Alchemia Ltd - Business Description
Alchemia Ltd - SWOT Analysis
SWOT Analysis - Overview
Alchemia Ltd - Strengths
Alchemia Ltd - Weaknesses
Alchemia Ltd - Opportunities
Alchemia Ltd - Threats
Alchemia Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Alchemia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Alchemia Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Alchemia Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jun 29, 2016: Alchemia Announces Resignation of Non-Executive Director
Apr 11, 2016: Alchemia Announces Change Of Company Secretary
Mar 07, 2016: Alchemia Announces Appointment of Non - Executive Director
Feb 29, 2016: Alchemia Announces Appointment of Non - Executive Chairman and Retirement of Non - Executive Chairman
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Alchemia Ltd, Key Facts 5
Alchemia Ltd, Key Employees 6
Alchemia Ltd, Key Employee Biographies 7
Alchemia Ltd, Major Products and Services 8
Alchemia Ltd, History 9
Alchemia Ltd, Subsidiaries 11
Alchemia Ltd, Key Competitors 17
Alchemia Ltd, Ratios based on current share price 18
Alchemia Ltd, Annual Ratios 19
Alchemia Ltd, Annual Ratios (Cont...1) 20
Alchemia Ltd, Interim Ratios 22
Alchemia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Alchemia Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 25
Alchemia Ltd, Recent Deals Summary 26
Currency Codes 31
Capital Market Ratios 31
Equity Ratios 32
Profitability Ratios 32
Cost Ratios 33
Liquidity Ratios 33
Leverage Ratios 34
Efficiency Ratios 34
List of Figures
Alchemia Ltd, Performance Chart (2013 - 2017) 21
Alchemia Ltd, Ratio Charts 23
Alchemia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Alchemia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 25

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report